A checked claim

…selling stock in his company just before his drug failed a clinical trial.

Ohioans for Lower Costs (organization) · A video advertisement, "Conman", by a group backed by the Democratic Governors Association · August 19, 2026 · Race: Governor of Ohio

About Vivek Ramaswamy.

Correct this page · hello@crackedbuckeye.com

The checks

Each in the checker's own words. This site does not restate another organization's finding in its own voice.

Democrats’ 'pump and dump' attacks against Vivek Ramaswamy don't add up

cleveland.com · no rating scale · September 17, 2026 · read the check

Fact checking political attack ads

WVXU · no rating scale · September 28, 2026 · read the check

Our check against the record

The record does not settle it

Checked against SEC filings: Ramaswamy's only Axovant Form 4 (April 29, 2016), a grant of 357,000 stock options with no common shares acquired or sold, and the Schedule 13D of Sept. 14, 2017 (event date Sept. 6, 2017), which reports all 75,000,000 Axovant common shares as directly owned by Roivant Sciences.

The records: Axovant Sciences, Form 4 filed for Vivek Ramaswamy (grant of stock options) · Axovant Sciences, Schedule 13D filed by SVF Investments (UK) Limited and related SoftBank Vision Fund entities

Context

The advertisement concerned Axovant Sciences, which Ramaswamy founded in 2014, and its Phase 3 trial of intepirdine, whose results were announced in September 2017.

Topics: Health care, Financial interests.

Other claims by Ohioans for Lower Costs

Every claim filed under Ohioans for Lower Costs

Sources

  1. Ohioans for Lower Costs Releases First Ads in Ohio Governor’s Race (with the "Conman" transcript) · Democratic Governors Association · 2026-08-19 · accessed 2026-10-03
  2. Democrats’ 'pump and dump' attacks against Vivek Ramaswamy don't add up · cleveland.com (via MSN) · 2026-09-17 · accessed 2026-10-03
  3. Axovant Sciences, Schedule 13D filed by SVF Investments (UK) Limited and related SoftBank Vision Fund entities · U.S. Securities and Exchange Commission (EDGAR) · 2017-09-14 · accessed 2026-10-03
  4. Axovant Sciences, Form 4 filed for Vivek Ramaswamy (grant of stock options) · U.S. Securities and Exchange Commission (EDGAR) · 2016-04-29 · accessed 2026-10-03

Cite and data

Cite this page as:

Cracked Buckeye, "Ohioans for Lower Costs: "…selling stock in his company just before his drug failed a clinical trial."", https://crackedbuckeye.com/claims/2026-08-19-ohioans-for-lower-costs-ramaswamy-selling-stock-before/, built 2026-11-02, accessed [date].

How to cite · Report a correction · Built 2026-11-02